ZOETIS INC.
ZTS US98978V1035
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 50% | -37% | 36% | -16% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Lagano Roxanne EX VP |
170.00 USD |
652 Sold |
110,840 USD |
03/06/2025 | 03/06/2025 |
| Lagano Roxanne EX VP |
170.00 USD |
652 Sold |
110,840 USD |
03/06/2025 | 03/06/2025 |
| Lagano Roxanne EX VP |
170.00 USD |
326 Sold |
55,420 USD |
10/03/2025 | 10/03/2025 |
| Peck Kristin C CEO |
156.68 USD |
382 Sold |
59,852 USD |
19/02/2025 | 19/02/2025 |
| Lagano Roxanne EX VP |
171.18 USD |
326 Sold |
55,805 USD |
08/02/2025 | 11/02/2025 |
| Polzer Robert J EX VP |
177.46 USD |
3,477 Sold |
617,028 USD |
25/11/2024 | 25/11/2024 |
| Lagano Roxanne EX VP |
151.17 USD |
923 Sold |
139,530 USD |
18/04/2024 | 18/04/2024 |
| Lagano Roxanne EX VP |
173.33 USD |
923 Sold |
159,984 USD |
18/03/2024 | 18/03/2024 |
| Reed Willie M |
182.68 USD |
1,370 Sold |
250,265 USD |
11/03/2024 | 11/03/2024 |
| Peck Kristin C CEO |
187.20 USD |
13,000 Sold |
2,433,636 USD |
20/02/2024 | 20/02/2024 |